Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 15/20 | 0.97 |
| ▸ | HDAC2 | Q92769 | 10/20 | 0.97 |
| ▸ | HDAC6 | Q9UBN7 | 8/20 | 0.97 |
| ▸ | HDAC8 | Q9BY41 | 7/20 | 0.97 |
| ▸ | HDAC3 | O15379 | 6/20 | 0.97 |
| ▸ | HDAC5 | Q9UQL6 | 6/20 | 0.97 |
| ▸ | HDAC4 | P56524 | 5/20 | 0.97 |
| ▸ | HDAC7 | Q8WUI4 | 5/20 | 0.97 |
| ▸ | HDAC10 | Q969S8 | 5/20 | 0.97 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.97 |
| ▸ | HDAC9 | Q9UKV0 | 5/20 | 0.97 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22849745 | 0.98 | HDAC1 (1.00) | HDAC1HDAC2HDAC6HDAC8HDAC3 | |
| SCHEMBL6386199 | 0.95 | HDAC1 (0.88) | HDAC1HDAC2HDAC6HDAC8HDAC3 | |
| SCHEMBL22190399 | 0.93 | HDAC1 (0.90) | HDAC1HDAC2HDAC6HDAC8HDAC3 | |
| SCHEMBL10588753 | 0.83 | HDAC1 (0.70) | HDAC1HDAC2HDAC6HDAC8HDAC3 | |
| SCHEMBL11959225 | 0.83 | HDAC1 (0.70) | HDAC1HDAC2HDAC6HDAC8HDAC3 | |
| SCHEMBL22190384 | 0.82 | HDAC1 (1.00) | HDAC1HDAC2HDAC6HDAC8HDAC3 | |
| SCHEMBL5807174 | 0.82 | HDAC1 (1.00) | HDAC1HDAC2HDAC6HDAC8HDAC3 | |
| SCHEMBL3844327 | 0.82 | HDAC1 (1.00) | HDAC1HDAC2HDAC6HDAC8HDAC3 | |
| SCHEMBL28446468 | 0.82 | HDAC1 (0.72) | HDAC1HDAC2HDAC6HDAC8HDAC3 | |
| SCHEMBL8610138 | 0.82 | HDAC1 (1.00) | HDAC1HDAC2HDAC6HDAC8HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0273451-B1 | LIPOXYGENASE INHIBITORY COMPOUNDS | Bristol-Myers Squibb Company (US) | 1992-04-01 | — | — | EP | disclosed |
| US-4861798-A | Lipoxygenase inhibitory compounds | BRISTOL-MYERS COMPANY (US) | 1989-08-29 | — | — | US | disclosed |
| EP-0273451-A2 | Lipoxygenase inhibitory compounds | Bristol-Myers Squibb Company (US) | 1988-07-06 | — | — | EP | disclosed |